Drug Discovery News Features Luxcel Biosciences in Special Cancer Metabolism Report

A really interesting article published in the recent June issue of Drug Discovery News featuring interviews with Ian Hayes Commercial Director and James Hynes Head of R&D at Luxcel Biosciences. Cell metabolism which is one of the key applications of the Luxcel Bioscience’ portfolio of in vitro cell based assay kits is central and core in orchestrating many of the fundamental roles of the cell and the decisions and functions of the cell such as proliferation and cell death amongst others. The article explores enhancing metabolic models, measuring cellular metabolism and targeting metabolism in cancer.

The Article is attached as a PDF below. 

Leave a Comment